Trials / Completed
CompletedNCT02355990
Minimally Invasive Micro Sclerostomy First in Man Safety and Preliminary Performance Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 96 (actual)
- Sponsor
- Sanoculis Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study objective is to demonstrate the safety of Minimally Invasive Micro Sclerostomy (MIMS) device for lowering elevated IOP in patients diagnosed with glaucoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Minimally Invasive Micro Sclerostomy | Creation of a drainage channel of 50 - 100 microns (diameter) at the sclera-corneal junction and extending from the anterior chamber to the interface between the sclera and the conjunctiva (subconjuctival space). |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2019-01-01
- Completion
- 2020-12-15
- First posted
- 2015-02-04
- Last updated
- 2022-11-30
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02355990. Inclusion in this directory is not an endorsement.